X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4138) 4138
Patent (145) 145
Conference Proceeding (128) 128
Publication (126) 126
Book Chapter (30) 30
Dissertation (25) 25
Technical Report (10) 10
Book / eBook (6) 6
Book Review (5) 5
Newspaper Article (3) 3
Data Set (2) 2
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1404) 1404
male (870) 870
animals (818) 818
female (795) 795
index medicus (748) 748
middle aged (467) 467
adult (423) 423
mice (383) 383
aged (358) 358
pharmacology & pharmacy (285) 285
oncology (256) 256
microbiology (233) 233
infectious diseases (209) 209
analysis (205) 205
expression (192) 192
neurosciences (185) 185
japan (159) 159
immunology (154) 154
research (144) 144
cancer (142) 142
biochemistry & molecular biology (138) 138
adolescent (136) 136
cells, cultured (133) 133
aged, 80 and over (128) 128
rats (127) 127
child (121) 121
molecular sequence data (120) 120
clinical neurology (117) 117
surgery (116) 116
chemistry (114) 114
cell line, tumor (110) 110
disease models, animal (110) 110
time factors (104) 104
treatment outcome (103) 103
immunohistochemistry (102) 102
cattle (101) 101
medicine & public health (101) 101
base sequence (98) 98
retrospective studies (95) 95
physics, applied (94) 94
child, preschool (93) 93
prognosis (93) 93
metallurgy (91) 91
polymerase chain reaction (90) 90
gene (87) 87
apoptosis (86) 86
cell line (85) 85
carcinoma (84) 84
mice, inbred balb c (83) 83
mutation (83) 83
infection (81) 81
activation (80) 80
gene expression (78) 78
medicine (78) 78
mice, inbred c57bl (78) 78
stomach neoplasms - pathology (78) 78
cell biology (77) 77
multidisciplinary sciences (76) 76
research article (75) 75
cells (74) 74
growth (73) 73
respiratory system (73) 73
identification (72) 72
proteins (72) 72
pathology (71) 71
dose-response relationship, drug (70) 70
health aspects (70) 70
medicine, general & internal (69) 69
care and treatment (68) 68
genetic aspects (68) 68
metastasis (67) 67
virology (67) 67
disease (66) 66
phosphorylation (66) 66
tumor cells, cultured (65) 65
pregnancy (64) 64
amino acid sequence (63) 63
article (63) 63
protein (63) 63
adrenal medulla - metabolism (62) 62
anti-bacterial agents - therapeutic use (62) 62
gastric cancer (62) 62
organic chemistry (62) 62
pediatrics (62) 62
stomach cancer (62) 62
diagnosis (61) 61
japan - epidemiology (61) 61
adrenal medulla - drug effects (60) 60
chemotherapy (60) 60
reverse transcriptase polymerase chain reaction (60) 60
hematology, oncology and palliative medicine (58) 58
pneumonia (58) 58
anti-bacterial agents - pharmacology (57) 57
follow-up studies (57) 57
dna (55) 55
stomach neoplasms - genetics (55) 55
genes (54) 54
inhibition (54) 54
phylogeny (54) 54
in-vitro (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4246) 4246
Japanese (427) 427
German (33) 33
French (27) 27
Swedish (7) 7
Chinese (6) 6
Korean (6) 6
Portuguese (6) 6
Spanish (3) 3
Danish (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1327 - 1335
Alogliptin, a new antihyperglycemic agent of the DPP-4 class, was shown to have no significant effect on cardiovascular risk over a median treatment period of... 
INHIBITOR ALOGLIPTIN | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR SAFETY | MELLITUS | OUTCOMES | MYOCARDIAL-INFARCTION | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Uracil - therapeutic use | Male | Myocardial Infarction - complications | Myocardial Infarction - drug therapy | Uracil - adverse effects | Angina, Unstable - drug therapy | Piperidines - therapeutic use | Angina, Unstable - complications | Piperidines - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Uracil - analogs & derivatives | Type 2 diabetes | Care and treatment | Acute coronary syndrome | Patient outcomes | Risk factors | Myocardial infarction | Heart attacks | Cardiovascular disease | Angina | Drug development | Hemoglobin | Diabetes mellitus (non-insulin dependent) | Drug dosages | Cerebral infarction | Stroke | Peptidase | Statistical analysis | Diabetes mellitus | Pancreatitis | Committees | FDA approval | Hypoglycemia | Angina pectoris | Studies | Product development | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Cancer
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9982, pp. 2067 - 2076
Journal Article
by Kitagawa, K and Yamamoto, Y and Arima, H and Maeda, T and Sunami, N and Kanzawa, T and Eguchi, K and Kamiyama, K and Minematsu, K and Ueda, S and Rakugi, H and Ohya, Y and Kohro, T and Yonemoto, K and Okada, Y and Higaki, J and Tanahashi, N and Kimura, G and Umemura, S and Matsumoto, M and Shimamoto, K and Ito, S and Saruta, T and Shimada, K and Kario, K and Saito, Y and Terayama, Y and Toyoda, K and Okura, T and Hoshino, H and Makino, H and Uchida, H and Uchiyama, S and Etani, H and Kohriyama, T and Tomimoto, H and Yoshio, T and Kobayashi, S and Usami, H and Iihoshi, S and Mikami, T and Mikuni, N and Miyata, K and Murakami, T and Endo, H and Fukui, T and Fumoto, K and Hara, K and Honjo, K and Kinoshita, Y and Maeda, M and Mikamoto, M and Mori, D and Murahashi, T and Nomura, R and Noro, S and Ogino, T and Okuma, M and Otake, Y and Shindo, K and Sugio, H and Takada, H and Takahira, K and Takeuchi, A and Watanabe, T and Yamaguchi, Y and Abumiya, T and Houkin, K and Matsumura, S and Shinohe, R and Kuroshima, K and Takizawa, K and Yoshida, K and Morimoto, H and Hasebe, N and Koyama, S and Maruyama, J and Irie, S and Nakano, T and Ogasawara, Y and Ohkuma, H and Shibanai, K and Hikichi, K and Moroi, J and Nakase, T and Okada, T and Takano, D and Takenaka, S and Yoshioka, S and Yanagisawa, T and Hirata, Y and Konno, S and Sato, T and Ito, M and Kondo, R and Mori, W and Saito, S and Kokubo, Y and Kato, H and Oyama, H and ... and Recurrent Stroke Prevention and Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group and for the Recurrent Stroke Prevention Clinical Outcome (RESPECT) Study Group
JAMA NEUROLOGY, ISSN 2168-6149, 11/2019, Volume 76, Issue 11, pp. 1309 - 1318
IMPORTANCE The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated that a systolic blood pressure (BP) target less than 120 mm Hg was superior to... 
TARGETS | EVENTS | REDUCTION | SECONDARY PREVENTION | CLINICAL NEUROLOGY | DISEASE | Stroke | Medical services | Health risks | Clinical trials | Strokes | Risk analysis | Patients | Meta-analysis | Prevention | Randomization | Design standards | Informed consent | Blood pressure | Risk management | Health risk assessment | Mercury | Cerebrovascular diseases | Index Medicus | Abridged Index Medicus
Journal Article